Authors:
RAJPUT AH
FENTON ME
SITTE H
PIFL C
HORNYKIEWICZ O
Citation: Ah. Rajput et al., BRAIN DOPAMINE (DA) METABOLISM IN DYSKINESIA AND WEARING OFF IN IDIOPATHIC PARKINSONS-DISEASE (PD), Neurology, 50(4), 1998, pp. 6055-6055
Citation: Ea. Singer et C. Pifl, A SUPERFUSION STUDY ON THE MECHANISM OF CARRIER-MEDIATED RELEASE IN CELLS STABLY EXPRESSING THE CLONED HUMAN DOPAMINE TRANSPORTER, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 91-91
Authors:
SITTE HH
HUCK S
REITHER H
BOEHM S
SINGER EA
PIFL C
Citation: Hh. Sitte et al., CARRIER-MEDIATED RELEASE, TRANSPORT RATES, AND CHARGE-TRANSFER INDUCED BY AMPHETAMINE, TYRAMINE, AND DOPAMINE IN MAMMALIAN-CELLS TRANSFECTED WITH THE HUMAN DOPAMINE TRANSPORTER, Journal of neurochemistry, 71(3), 1998, pp. 1289-1297
Citation: Wa. Rinner et al., INDUCTION OF APOPTOSIS IN-VITRO AND IN-VIVO BY THE CHOLINERGIC NEUROTOXIN ETHYLCHOLINE AZIRIDINIUM, Neuroscience, 79(2), 1997, pp. 535-542
Authors:
SITTE HH
HUCK S
REITHER H
BOEHM S
SINGER EA
PIFL C
Citation: Hh. Sitte et al., AMPHETAMINE-INDUCED CHARGE-TRANSFER IN THE HUMAN DOPAMINE TRANSPORTER- IMPORTANCE FOR CARRIER-MEDIATED RELEASE, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 80-80
Citation: Hh. Sitte et al., DISCREPANCY BETWEEN CHARGE-TRANSFER AND SUBSTRATE TRANSLOCATION IN ELECTROPHYSIOLOGICAL AND UPTAKE STUDIES ON THE DOPAMINE TRANSPORTER, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 69-69
Authors:
PIFL C
AGNETER E
DROBNY H
REITHER H
SINGER EA
Citation: C. Pifl et al., INDUCTION BY LOW NA- OF COCAINE-SENSITIVE CARRIER-MEDIATED EFFLUX OF AMINES FROM CELLS TRANSFECTED WITH THE CLONED HUMAN CATECHOLAMINE TRANSPORTERS( OR CL), British Journal of Pharmacology, 121(2), 1997, pp. 205-212
Authors:
WILSON JM
LEVEY AI
RAJPUT A
ANG L
GUTTMAN M
SHANNAK K
NIZNIK HB
HORNYKIEWICZ O
PIFL C
KISH SJ
Citation: Jm. Wilson et al., DIFFERENTIAL CHANGES IN NEUROCHEMICAL MARKERS OF STRIATAL DOPAMINE NERVE-TERMINALS IN IDIOPATHIC PARKINSONS-DISEASE, Neurology, 47(3), 1996, pp. 718-726
Citation: C. Pifl et al., CATECHOLAMINE TRANSPORTERS AND 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE NEUROTOXICITY - STUDIES COMPARING THE CLONED HUMAN NORADRENALINE AND HUMAN DOPAMINE TRANSPORTER, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1437-1443
Authors:
PIFL C
DROBNY H
REITHER H
HORNYKIEWICZ O
SINGER EA
Citation: C. Pifl et al., MECHANISM OF THE DOPAMINE-RELEASING ACTIONS OF AMPHETAMINE AND COCAINE - PLASMALEMMAL DOPAMINE TRANSPORTER VERSUS VESICULAR MONOAMINE TRANSPORTER, Molecular pharmacology, 47(2), 1995, pp. 368-373
Authors:
GIROS B
WANG YM
SUTER S
MCLESKEY SB
PIFL C
CARON MG
Citation: B. Giros et al., DELINEATION OF DISCRETE DOMAINS FOR SUBSTRATE, COCAINE, AND TRICYCLICANTIDEPRESSANT INTERACTIONS USING CHIMERIC DOPAMINE-NOREPINEPHRINE TRANSPORTERS, The Journal of biological chemistry, 269(23), 1994, pp. 15985-15988
Citation: C. Pifl et al., DOPAMINE TRANSPORTER EXPRESSION CONFERS CYTOTOXICITY TO LOW-DOSES OF THE PARKINSONISM-INDUCING NEUROTOXIN 1-METHYL-4-PHENYLPYRIDINIUM, The Journal of neuroscience, 13(10), 1993, pp. 4246-4253